These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


96 related items for PubMed ID: 9299401

  • 1. Expression and molecular characterization of an enzymatically active recombinant human spumaretrovirus protease.
    Pfrepper KI, Löchelt M, Schnölzer M, Flügel RM.
    Biochem Biophys Res Commun; 1997 Aug 28; 237(3):548-53. PubMed ID: 9299401
    [Abstract] [Full Text] [Related]

  • 2. Molecular characterization of proteolytic processing of the Gag proteins of human spumaretrovirus.
    Pfrepper KI, Flügel RM.
    Methods Mol Biol; 2005 Aug 28; 304():435-44. PubMed ID: 16061995
    [Abstract] [Full Text] [Related]

  • 3. Recombinant human cytomegalovirus protease with a C-terminal (His)6 extension: purification, autocatalytic release of the mature enzyme, and biochemical characterization.
    Tomasselli AG, Paddock DJ, Curry KA, Garlick RL, Leone JW, Lull JM, Mutchler VT, Baker CA, Cavey GS, Mathews WR, Shelly JA, Finzel BC, Baldwin ET, Wells PA, Tomich CS.
    Protein Expr Purif; 1998 Dec 28; 14(3):343-52. PubMed ID: 9882568
    [Abstract] [Full Text] [Related]

  • 4. Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme.
    Menéndez-Arias L, Gotte D, Oroszlan S.
    Virology; 1993 Oct 28; 196(2):557-63. PubMed ID: 8372434
    [Abstract] [Full Text] [Related]

  • 5. Molecular biological characterization of the human foamy virus reverse transcriptase and ribonuclease H domains.
    Kögel D, Aboud M, Flügel RM.
    Virology; 1995 Oct 20; 213(1):97-108. PubMed ID: 7483284
    [Abstract] [Full Text] [Related]

  • 6. Avian sarcoma leukemia virus protease linked to the adjacent Gag polyprotein is enzymatically active.
    Arad G, Bar-Meir R, Almog N, Chorev M, Kotler M.
    Virology; 1995 Dec 20; 214(2):439-44. PubMed ID: 8553545
    [Abstract] [Full Text] [Related]

  • 7. Monitoring cleavage of fusion proteins by matrix-assisted laser desorption ionization/mass spectrometry: recombinant HIV-1IIIB p26.
    Parker CE, Papac DI, Tomer KB.
    Anal Biochem; 1996 Jul 15; 239(1):25-34. PubMed ID: 8660621
    [Abstract] [Full Text] [Related]

  • 8. Effect of mutations on the dimer stability and the pH optimum of the human foamy virus protease.
    Sperka T, Boross P, Eizert H, Tözsér J, Bagossi P.
    Protein Eng Des Sel; 2006 Aug 15; 19(8):369-75. PubMed ID: 16799151
    [Abstract] [Full Text] [Related]

  • 9. Protein composition and morphology of human foamy virus intracellular cores and extracellular particles.
    Morozov VA, Copeland TD, Nagashima K, Gonda MA, Oroszlan S.
    Virology; 1997 Feb 17; 228(2):307-17. PubMed ID: 9123838
    [Abstract] [Full Text] [Related]

  • 10. Identification of pol-related gene products of human foamy virus.
    Netzer KO, Schliephake A, Maurer B, Watanabe R, Aguzzi A, Rethwilm A.
    Virology; 1993 Jan 17; 192(1):336-8. PubMed ID: 8390761
    [Abstract] [Full Text] [Related]

  • 11. Production of chemokines CTAPIII and NAP/2 by digestion of recombinant ubiquitin-CTAPIII with yeast ubiquitin C-terminal hydrolase and human immunodeficiency virus protease.
    Mildner AM, Paddock DJ, LeCureux LW, Leone JW, Anderson DC, Tomasselli AG, Heinrikson RL.
    Protein Expr Purif; 1999 Jul 17; 16(2):347-54. PubMed ID: 10419831
    [Abstract] [Full Text] [Related]

  • 12. Linkers for improved cleavage of fusion proteins with an engineered alpha-lytic protease.
    Lien S, Milner SJ, Graham LD, Wallace JC, Francis GL.
    Biotechnol Bioeng; 2001 Aug 20; 74(4):335-43. PubMed ID: 11410858
    [Abstract] [Full Text] [Related]

  • 13. High level expression and single-step purification of hexahistidine-tagged L-2-hydroxyisocaproate dehydrogenase making use of a versatile expression vector set.
    Chatterjee S, Schoepe J, Lohmer S, Schomburg D.
    Protein Expr Purif; 2005 Feb 20; 39(2):137-43. PubMed ID: 15642463
    [Abstract] [Full Text] [Related]

  • 14. Expression of the murine leukemia virus protease in fusion with maltose-binding protein in Escherichia coli.
    Fehér A, Boross P, Sperka T, Oroszlan S, Tözsér J.
    Protein Expr Purif; 2004 May 20; 35(1):62-8. PubMed ID: 15039067
    [Abstract] [Full Text] [Related]

  • 15. A new strategy for glycoprotein synthesis: ligation of synthetic glycopeptides with truncated proteins expressed in E. coli as TEV protease cleavable fusion protein.
    Tolbert TJ, Franke D, Wong CH.
    Bioorg Med Chem; 2005 Feb 01; 13(3):909-15. PubMed ID: 15653356
    [Abstract] [Full Text] [Related]

  • 16. Preparation of recombinant thioredoxin fused N-terminal proCNP: Analysis of enterokinase cleavage products reveals new enterokinase cleavage sites.
    Liew OW, Ching Chong JP, Yandle TG, Brennan SO.
    Protein Expr Purif; 2005 Jun 01; 41(2):332-40. PubMed ID: 15866719
    [Abstract] [Full Text] [Related]

  • 17. Proteolytic activity of purified avian sarcoma and leukemia virus NC-PR protein expressed in Escherichia coli.
    Séllos-Moura M, Vogt VM.
    Virology; 1996 Jul 15; 221(2):335-45. PubMed ID: 8661444
    [Abstract] [Full Text] [Related]

  • 18. An improved strategy for high-level production of TEV protease in Escherichia coli and its purification and characterization.
    Fang L, Jia KZ, Tang YL, Ma DY, Yu M, Hua ZC.
    Protein Expr Purif; 2007 Jan 15; 51(1):102-9. PubMed ID: 16919473
    [Abstract] [Full Text] [Related]

  • 19. Molecular characterization of proteolytic processing of the Gag proteins of human spumavirus.
    Pfrepper KI, Löchelt M, Rackwitz HR, Schnölzer M, Heid H, Flügel RM.
    J Virol; 1999 Sep 15; 73(9):7907-11. PubMed ID: 10438890
    [Abstract] [Full Text] [Related]

  • 20. Bovine leukemia virus: purification and characterization of the aspartic protease.
    Menard A, Mamoun RZ, Geoffre S, Castroviejo M, Raymond S, Precigoux G, Hospital M, Guillemain B.
    Virology; 1993 Apr 15; 193(2):680-9. PubMed ID: 8384751
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.